Jafari et al. also found that after silencing α-NaGalase in the cells of human gastric adenocarcinoma, α-NaGalase downregulation had augmentative and regressive effects on cell death and migration, but no significant difference in daunorubicin resistance was observed [17]. This evidence concerns the gene NAGA and gastric adenocarcinoma.